InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: MADDSTACKER post# 8106

Thursday, 09/06/2018 7:48:16 PM

Thursday, September 06, 2018 7:48:16 PM

Post# of 11473
I just listened to the Emerald Health Pharma webcast with Jim DeMesa. I have to say I am very impressed with what they are working on. Multiple sclerosis (MS), scleroderma, Huntington's disease are the indications they are going after in the near-term. Proven effectiveness in animal trials and orphan drug status for 2 indications. They are planning a U.S. IPO within the next year and a half when they are into phase II human trials.

I would assume current holders of EMHTF will benefit when they IPO. If we are a $100 stock in 2 years a spinoff would be very lucrative at that point.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.